Stockscreener 앱 받기
0.8239
1.08%
-0.009
시간 외 거래:
.82
-0.0039
-0.47%
Atyr Pharma Inc 주식(ATYR)의 최신 뉴스
ATyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - marketscreener.com
ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that aTyr Pharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Holzer & Holzer, LLC Reminds Investors of Upcoming December - GlobeNewswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
Deadline Soon: aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - The AI Journal
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - PR Newswire
ATyr Pharma, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your Rights - 富途牛牛
aTyr Pharma, Inc. $ATYR Shares Bought by Geode Capital Management LLC - Defense World
ATYR 5-DAY DEADLINE ALERT: Hagens Berman Urges aTyr Pharma Inves - GuruFocus
Shareholders SueWallSt in New Class Action Against aTyr Pharma, Inc.Act Now - Nasdaq
ATYR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - GlobeNewswire
ATYR Deadline: ATYR Investors with Losses Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit - PR Newswire
Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - MarketScreener
Deadline Alert: aTyr Pharma Inc. (ATYR) Shareholders Who - GlobeNewswire
Shareholders that lost money on aTyr Pharma, Inc.(ATYR) should c - GuruFocus
Portnoy Law Firm Announces Class Action on Behalf of aTyr Pharma, Inc. Investors - GlobeNewswire
The Gross Law Firm Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineATYR - Lelezard
Will aTyr Pharma Inc. (471A) stock profit from fiscal stimulusQuarterly Risk Review & Low Volatility Stock Recommendations - Newser
How aTyr Pharma Inc. (471A) stock valuation compares with sectorMarket Trend Review & Consistent Profit Trading Strategies - Newser
ATYR 1-WEEK DEADLINE ALERT: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure - PR Newswire
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - MarketScreener
Bragar Eagel & Squire, P.C. Urgently Reminds Stockholders - GlobeNewswire
Lost Money on aTyr Pharma, Inc.(ATYR)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - GlobeNewswire
aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securi - GuruFocus
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Levi & Korsinsky Notifies aTyr Pharma, Inc. (ATYR) InvestorsLead Plaintiff Deadline on December 8, 2025 - Stockhouse
ATYR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that aTyr Pharma, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ATYR DEADLINE: Faruqi & Faruqi Reminds aTyr Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 8, 2025ATYR - PR Newswire
Shareholders of aTyr Pharma, Inc. (ATYR): Protect Your Rights Before December 8, 2025Contact Levi & Korsinsky - Stockhouse
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - GlobeNewswire
ATYR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages - GlobeNewswire
ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure - Prime Publishers, Inc.
2025-11-28 | Securities Fraud Class Action Filed Against aTyr Pharma, Inc. (ATYR)Levi & Korsinsky Reminds Investors of December 8, 2025 | NDAQ:ATYR | Press Release - Stockhouse
ATYR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that aTyr Pharma, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
ATYR INVESTOR NOTICE: Faruqi & Faruqi, LLP Announces that aTyr Pharma Investors Have Opportunity to Lead Class Action Lawsuit - MarketScreener
ATYR Deadline: ATYR Investors with Losses in Excess of $100K Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit - Your Wyoming Link
The Short List — Top 10 Most Shorted Stocks Right Now - Sahm
aTyr Pharma (ATYR) Securities Class Action Pending Over Key Drug's Efficacy -- Hagens Berman - GuruFocus
ATyr Pharma (ATYR) Securities Class Action Pending Over Key Drug's Efficacy -- Hagens Berman - MarketScreener
aTyr Pharma (ATYR) Securities Class Action Pending Over Key Drug's Efficacy — Hagens Berman - Morningstar
ATYR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that aTyr Pharma, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
aTyr Pharma (ATYR) Posts Wider-Than-Expected Loss as Investor Litigation Over Key Drug's Efficacy Moves ForwardHagens Berman - The Malaysian Reserve
aTyr Pharma, Inc. Sued for Securities Law Violations - GlobeNewswire
aTyr Pharma (ATYR) Posts Wider-Than-Expected Loss as Investor Litigation Over Key Drug's Efficacy Moves Forward -- Hagens Berman - Barchart.com
Recover Investment Losses: Class Action Initiated Against aTyr Pharma, Inc. (ATYR) - Stockhouse
aTyr Pharma Faces Class Action after Clinical Trial Failure Raises Investor Concerns - TipRanks
ATYR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that aTyr Pharma, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Shareholders that lost money on aTyr Pharma, Inc.(ATYR) Urged to - GuruFocus
Shareholders that lost money on aTyr Pharma, Inc.(ATYR) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - WV News
Traws Pharma Inc (TRAW) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
You might want to take a look at Atyr Pharma Inc (ATYR) now - Setenews
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - MarketScreener
Bragar Eagel & Squire, P.C. Urges Investors of aTyr, Marex, - GlobeNewswire
aTyr Pharma (ATYR) Posts Wider-Than-Expected Loss as - GlobeNewswire
Investors Who Lost Money on aTyr Pharma, Inc. (ATYR) Should Contact Levi & Korsinsky About Pending Class ActionATYR - NewMediaWire
Shareholders that lost money on aTyr Pharma, Inc.(ATYR) - GlobeNewswire
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of aTyr Pharma, Inc.(ATYR) Shareholders - PR Newswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds aTyr Pharma, Inc. (ATYR) Investors of December 8, 2025 Deadline - ACCESS Newswire
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages aTyr - GlobeNewswire
1.44%
0.91%
자본화:
|
볼륨(24시간):